San Diego-based Panmira Pharmaceuticals LLC is not the traditional biotech start-up. Founded this month to develop assets spun out ahead of Bristol-Myers Squibb Co.'s July acquisition of Amira Pharmaceuticals Inc., the new company really could be labeled Amira Part Two.